Atrial Fibrillation and Congestive Heart Failure: A Cost Analysis of Rhythm-Control vs Rate-Control Strategies

Canadian Journal of Cardiology

Volumn 29, Issue 10, 2013, Pages 1256-1262

  Poulin, Frédéric ^a   Khairy, Paul ^a   Roy, Denis ^a   Levesque, Sylvie ^a   Talajic, Mario ^a   Guertin, Jason R ^b   LeLorier, Jacques ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CANADA; CARDIOVERSION; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST MINIMIZATION ANALYSIS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE CHAMBER PACEMAKER;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR AGENTS; COST-BENEFIT ANALYSIS; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HOSPITAL COSTS; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; QUEBEC;

EID: 84884593042     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.03.005     Document Type: Article

References (20)

1. Ross H., Howlett J., Arnold J.M., et al. Treating the right patient at the right time: access to heart failure care. Can J Cardiol 2006, 22:749-754.
2. 2004 Canadian Cardiovascular Society consensus conference: atrial fibrillation. Can J Cardiol 2005, 21(suppl B):9B-73B.
3. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
4. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. NEngl J Med 2008, 358:2667-2677.
5. Talajic M., Khairy P., Levesque S., et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. JAm Coll Cardiol 2010, 55:1796-1802.
6. Tamblyn R., Lavoie G., Petrella L., Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. JClin Epidemiol 1995, 48:999-1009.
7. Tamblyn R., Reid T., Mayo N., McLeod P., Churchill-Smith M. Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment. JClin Epidemiol 2000, 53:183-194.
8. Suman-Horduna I., Roy D., Frassure-Smith N., et al. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. JAm Coll Cardiol 2013, 61:455-460.
9. Consumer price indexes. Available at: Accessed June 25, 2010. http://www5.statcan.gc.ca/cansim/a26?lang%3Deng%26retrLang%3Deng%26id%3D3260021%26tabMode%3DdataTable%26srchLan%3D-1%26p1%3D-1%26p2%3D9.
10. Ontario Case Costing Initiative. Available at: Accessed June 1, 2010. http://www.occp.com/.
11. Marshall D.A., Levy A.R., Vidaillet H., et al. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004, 141:653-661.
12. Monfared A.A., Lelorier J. Accuracy and validity of using medical claims data to identify episodes of hospitalizations in patients with COPD. Pharmacoepidemiol Drug Saf 2006, 15:19-29.
13. Manuel des médecins spécialistes (no 150). Régie de l'assurance maladie du Québec. 2009. Available at: Accessed July 20, 2009. http://www.ramq.gouv.qc.ca/fr/professionnels/medspe/manuel/man150.shtml.
14. Manuel des médecins omnipraticiens (no 100). Régie de l'assurance maladie du Québec; 2010. Available at: Accessed March 10, 2011. http://www.ramq.gouv.qc.ca/fr/professionnels/medomni/manuel/man100.shtml.
15. Medical Advisory Secretariat Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Ont Health Technol Assess Ser 2005, 5:1-60.
16. Medical Advisory Secretariat Advanced electrophysiologic mapping systems: an evidence-based analysis. Ont Health Technol Assess Ser 2006, 6:1-101.
17. Desgagne A., Castilloux A.M., Angers J.F., LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998, 13:487-497.
18. Carpenter J., Bithell J. Bootstrap confidence intervals: when, which, what? a practical guide for medical statisticians. Stat Med 2000, 19:1141-1164.
19. Catherwood E., Fitzpatrick W.D., Greenberg M.L., et al. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med 1999, 130:625-636.
20. Eckman M.H., Falk R.H., Pauker S.G. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med 1998, 158:1669-1677.